Mimedx (MDXG) Net Cash Flow (2011 - 2026)

Mimedx has disclosed Net Cash Flow across 16 years of filings, most recently posting -$23.9 million for Q2 2026.

• In Q2 2026, Net Cash Flow fell 292.43% year-over-year to -$23.9 million; the TTM figure through Jun 2026 stood at $17.0 million (down 65.95% YoY), while the FY2025 annual figure was $61.7 million, up 164.31% from the prior year.
• Net Cash Flow came in at -$23.9 million for Q2 2026 at Mimedx, down from -$6.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $24.0 million in Q4 2025 to a low of -$32.7 million in Q1 2024.
• Average Net Cash Flow over 5 years is $3.2 million, with a median of $1.4 million recorded in 2022.
• Year-over-year, Net Cash Flow tumbled 1316.09% in 2022 and soared 10440.4% in 2024.
• Over 5 years, Net Cash Flow stood at -$7.3 million in 2022, then soared by 97.92% to -$151000.0 in 2023, then soared by 10440.4% to $15.6 million in 2024, then jumped by 53.95% to $24.0 million in 2025, then tumbled by 199.57% to -$23.9 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$23.9 million in Q2 2026, -$6.3 million in Q1 2026, and $24.0 million in Q4 2025.